Semglee (insulin glargine-yfgn) is a biosimilar basal insulin with the same chemical composition as insulin glargine. However, since it is a biosimilar, it is a less costly version of this … Continue reading First Interchangeable Biosimilar Insulin Approved
For our June 22nd Question of the Week, 64% of respondents chose the best answer. Since many diabetes specialists aren’t exposed to the care of people with diabetes during pregnancy, … Continue reading Rationale of the Week | How do Pregnancy Hormones affect Glucose?
AR is living with type 2 diabetes, has an A1c of 7.4%, and takes metformin 1000 BID and 60 units of glargine at bedtime. AR is admitted to the hospital … Continue reading Question of the Week | Prepping for Surgery
ML has type 1 diabetes, her A1c is on target and she and is hoping to get pregnant in the upcoming year. Which of the following statement best reflects the … Continue reading Question of the Week | How do Pregnancy Hormones affect Glucose?
For our June 8th Question of the Week, only 64% of respondents chose the best answer. We want to “take a closer look” at this question and determine strategies to … Continue reading Rationale of the Week | JR worried about cancer; sorting fact from fiction
Written by Monique Jackson, MSN, CFNP, WHCNP, CDCES A new study finds that hemoglobinopathies may distort A1C accuracy for people of African descent living with diabetes. African Americans at risk for falsely low … Continue reading A1c may not accurately Diagnose Diabetes in People of African Descent
RT is 12 years old and has a new diagnosis of type 1 diabetes. Based on the ADA Standards of Care, what is the most accurate statement regarding glycemic goals? … Continue reading Question of the Week | What are Pediatric Glucose Targets?
For our June 1st Question of the Week, only 45% of respondents chose the best answer. We want to “take a closer look” at this question and figure out how … Continue reading Rationale of the Week – Less than 50% chose best answer | New Type 2, Action Needed?